GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Reshape Lifesciences Inc (STU:24O0) » Definitions » Cyclically Adjusted PB Ratio

Reshape Lifesciences (STU:24O0) Cyclically Adjusted PB Ratio : (As of Jun. 04, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Reshape Lifesciences Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Reshape Lifesciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Reshape Lifesciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reshape Lifesciences Cyclically Adjusted PB Ratio Chart

Reshape Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Reshape Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Reshape Lifesciences's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Reshape Lifesciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reshape Lifesciences's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Reshape Lifesciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Reshape Lifesciences's Cyclically Adjusted PB Ratio falls into.



Reshape Lifesciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Reshape Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Reshape Lifesciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.208/131.7762*131.7762
=1.208

Current CPI (Mar. 2024) = 131.7762.

Reshape Lifesciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 7.982 100.560 10.460
201409 5.894 100.428 7.734
201412 68.418 99.070 91.005
201503 69.680 99.621 92.171
201506 12.889 100.684 16.869
201509 49.626 100.392 65.140
201512 42.684 99.792 56.364
201603 -565.500 100.470 -741.705
201606 -1,071.000 101.688 -1,387.894
201609 93.545 101.861 121.018
201612 253.273 101.863 327.650
201703 144.655 102.862 185.317
201706 3,381.500 103.349 4,311.612
201709 3,293.846 104.136 4,168.128
201712 537,741.667 104.011 681,288.377
201803 445,191.667 105.290 557,184.393
201806 159,414.286 106.317 197,588.799
201809 6,178.600 106.507 7,644.518
201812 380.829 105.998 473.445
201903 393.753 107.251 483.795
201906 49.893 108.070 60.838
201909 -40.200 108.329 -48.901
201912 55.381 108.420 67.311
202003 49.824 108.902 60.290
202006 3.044 108.767 3.688
202009 2.596 109.815 3.115
202012 1.931 109.897 2.315
202103 1.731 111.754 2.041
202106 295.275 114.631 339.438
202109 190.341 115.734 216.724
202112 110.016 117.630 123.247
202203 94.292 121.301 102.435
202206 77.982 125.017 82.198
202209 46.806 125.227 49.254
202212 6.656 125.222 7.004
202303 2.736 127.348 2.831
202306 1.801 128.729 1.844
202309 0.837 129.860 0.849
202312 1.770 129.419 1.802
202403 1.208 131.776 1.208

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Reshape Lifesciences  (STU:24O0) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Reshape Lifesciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Reshape Lifesciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Reshape Lifesciences (STU:24O0) Business Description

Traded in Other Exchanges
Address
1001 Calle Amanecer, San Clemente, CA, USA, 92673
Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Reshape Lifesciences (STU:24O0) Headlines

No Headlines